Articles on Vioxx

Displaying all articles

Federal agencies of the executive branch must comply with requests for public records through the Freedom of Information Act. designer491/iStock via Getty Images Plus

The sudden dismissal of public records staff at health agencies threatens government accountability

Public records requested under the Freedom of Information Act have helped shape health policy and keep the government accountable – but recent staff cuts may make this impossible.
Public health measures such as vaccine and mask mandates, lockdowns and school closures have been widely discussed in scientific and popular media. THE CANADIAN PRESS/Lars Hagberg

Public health errors: Why it’s crucial to understand what they are before assessing COVID‑19 responses

As the COVID-19 pandemic fades, we may debate whether public health responses could have been better. But first we need to understand what public health errors are — and are not.
Vioxx is the quintessential story of what can go wrong when a big pharmaceutical company exerts influence over the evidence base. AAP

Pharma’s influence over published clinical evidence

TRANSPARENCY AND MEDICINE – A series examining issues from ethics to the evidence in evidence-based medicine, the influence of medical journals to the role of Big Pharma in our present and future health…
Vioxx was withdrawn from the Australian market in October 2004 and there’s an ongoing compensation case. DaGoaty/Flickr

Vioxx withdrawal: making sense of the fight for compensation in Australia

The enormous medical impact of modern pharmaceuticals has on occasion been matched by some large-scale litigation regarding adverse events. The Vioxx litigation in Australia and elsewhere is one such recent…

Top contributors

More